Michele Carbone, was published in the
Journal of Thoracic Oncology. Accessible to the public and written in lay language, topics covered include origin, coronavirus background, detection, death rates, transmission, susceptibility, developing therapies, vaccines and more.
The article seeks to provide experts, public health authorities and the general public with a reliable scientific source of information regarding facts about the COVID-19 pandemic. In addition, the article discusses the future of the pandemic addressing questions about when the pandemic will end, and when life can return to the way it used to be.
“The goal of this publication is to help people better understand the virus and how to best protect themselves from the infection. We also want to present the facts in a clear and simple way, as there has been a lot of confusion and misinformation being spread about the virus,” said Carbone.
E-Mail
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls. The final results were published online on Jan. 21 in
Cancer Discovery, a journal of the American Association for Cancer Research.
Advances in technology have made it possible for scientists and physicians to use information about the genetic makeup of a cancerous tumor to inform cancer treatment, but genetic heterogeneity the genetic variation between cancers in different patients and even between tumors within the same patient can make it difficult to determine the most effective targeting strategy for treating individual patients.